Enterprise Value
-14.21M
Cash
52.75M
Avg Qtr Burn
-9.054M
Short % of Float
0.28%
Insider Ownership
14.78%
Institutional Own.
37.13%
Qtr Updated
09/30/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MET642 Details Ulcerative colitis | Failed Discontinued | |
MET409 Details Non-alcoholic steatohepatitis , Liver disease | Failed Discontinued |